AMAR is a specialized Biomedical Program Management and Product Development Company skilled in health sciences-related IT support services, lab and clinical research, healthcare product development, clinical trials, and regulatory affairs management. The company is a Small Business Administration (SBA)-certified 8(a), Small Disadvantaged and Woman-Owned Business (SDB-WOSB) established by former NIH biomedical scientists and incorporated in 1999. Built on NIH Standard Operating Procedures (SOPs), AMAR has serviced NIH as a prime contractor for the last eight (8) years, and is well known for its subject matter expertise in biomedical research and study management.
AMAR has been supporting the Government in a number of programs for more than eight years. It is experienced in supporting the Government in biomedical program management, clinical research, data and bio-statistical analysis, bioinformatics, healthcare databases and data storage, regulatory affairs, healthcare product development, web development and support, NIH study data storage and sharing, coordination of NIH cooperative studies and publication, and other miscellaneous services required in NIH-funded cooperative programs.
Managed NIH programs since 2003; currently involved in working with 10 study centers, 40+ study sites, 40 Principle Investigators (PI) and co-PIs, over 400 NIH study participants all across the continental United States (U.S.) and Puerto Rico (P.R.).
Lead PI has experience in biomedical and technology management programs worth over $1.5 billion in the U.S. Government.
Currently manage the largest drug abuse treatment study at NIH (NIDA) as a prime contractor. AMAR is also managing one of the largest vaccine development programs for biodefense pathogens (NIH National Institute of Allergy and Infectious Diseases [NIAID] IBT) that are needed in national stock pile.
AMAR principals are invited by NIH as grant reviewers and speakers for their subject matter expertise.